Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mackenzie Financial Corp raised its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.7% during the 3rd quarter, Holdings Channel.com reports. The firm owned 491,927 shares of the biopharmaceutical company’s stock after acquiring an additional 13,090 shares during the quarter. Mackenzie Financial Corp’s holdings in Gilead Sciences were worth $36,043,000 as […]
Brighton Jones LLC increased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,349 shares of the biopharmaceutical company’s stock after acquiring an additional 301 […]
WESPAC Advisors LLC bought a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,928 shares of the biopharmaceutical company’s stock, valued at approximately $219,000. A number of other institutional investors have […]
Telemus Capital LLC lifted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 379.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,801 shares of the biopharmaceutical company’s stock after buying an additional 14,088 shares during […]
Rovin Capital UT ADV grew its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 83.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 5,708 shares of the biopharmaceutical company’s stock after acquiring an additional 2,604 shares during the period. Rovin Capital UT ADV’s […]